Top compounds associated with response to PELI1


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 GDSC1000 pan-cancer AAC -0.2 0.0002
mRNA masitinib GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA PD318088 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA XL-184 GDSC1000 pan-cancer AAC -0.13 0.0004
mRNA Imatinib GDSC1000 pan-cancer AAC -0.2 0.0004
mRNA bid1870 gCSI pan-cancer AAC -0.21 0.0004
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.12 0.0005
Download CSV